ACADIA Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	3,603	4,549	3,059	5,155	2,580	3,758
Market Cap Growth	-3.29%	48.70%	-40.66%	99.81%	-31.34%	-55.96%
Enterprise Value	2,802	3,770	2,345	4,764	2,216	3,293
Last Close Price	21.04	26.71	18.35	31.31	15.92	23.34
PE Ratio	9.51	11.61	13.49	-	-	-
Forward PE	38.53	40.38	35.90	27.40	-	-
PS Ratio	3.29	4.25	3.19	7.10	4.99	7.76
PB Ratio	2.86	3.71	4.17	11.94	6.44	6.95
P/TBV Ratio	2.88	3.70	4.17	11.88	6.43	6.93
P/FCF Ratio	31.72	43.26	19.46	309.58	-	-
P/OCF Ratio	29.17	41.42	19.40	308.66	-	-
EV/Sales Ratio	2.56	3.52	2.45	6.56	4.28	6.80
EV/EBITDA Ratio	30.23	32.34	9.51	-	-	-
EV/EBIT Ratio	34.63	35.97	10.16	-	-	-
EV/FCF Ratio	24.67	35.85	14.92	286.10	-	-
Debt / Equity Ratio	0.03	0.03	0.06	0.11	0.13	0.10
Debt / EBITDA Ratio	0.42	0.35	0.17	-	-	-
Debt / FCF Ratio	0.34	0.39	0.27	2.87	-	-
Net Debt / Equity Ratio	-0.65	-0.63	-0.97	-0.91	-0.91	-0.86
Net Debt / EBITDA Ratio	-8.76	-6.68	-2.89	5.77	1.63	2.78
Net Debt / FCF Ratio	-7.15	-7.41	-4.54	-23.48	3.19	3.66
Asset Turnover	0.69	0.78	0.99	1.09	0.80	0.65
Inventory Turnover	2.82	3.14	2.83	1.96	1.40	2.18
Quick Ratio	3.27	3.49	2.18	2.13	3.82	6.10
Current Ratio	3.59	3.83	2.38	2.42	4.04	6.43
Return on Equity (ROE)	30.35%	39.89%	38.89%	-14.73%	-45.89%	-28.75%
Return on Assets (ROA)	16.66%	21.44%	20.91%	-13.18%	-35.13%	-23.04%
Return on Invested Capital (ROIC)	57.67%	117.01%	436.78%	-174.15%	-351.57%	-266.79%
Return on Capital Employed (ROCE)	6.26%	10.08%	35.85%	-15.34%	-41.94%	-26.62%
Earnings Yield	10.43%	8.61%	7.41%	-	-	-
FCF Yield	3.15%	2.31%	5.14%	0.32%	-	-
Buyback Yield / Dilution	-2.73%	-2.14%	-1.55%	-1.32%	-0.74%	-2.01%
Total Shareholder Return	-2.73%	-2.14%	-1.55%	-1.32%	-0.74%	-2.01%

SEC Filings: 10-K · 10-Q